Strategies to reduce dynamic hyperinflation in chronic obstructive pulmonary disease by Casaburi, Richard
www.pneumonologia.viamedica.pl
PRACA ORYGINALNA
192
EDUK CJ
Address for correspondence: Richard Casaburi, PhD, MD, Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical
Building J-4, 1124 W. Carson Street, Torrance, CA 90502, USA, tel.: 001 310 222–8249, fax: 001 310 222–8200, e-mail: casaburi@ucla.edu
Praca wpłynęła do Redakcji: 21.01.2009 r.
Copyright © 2009 Via Medica
ISSN 0867–7077
Richard Casaburi
Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center,
Torrance, CA, Stany Zjednoczone
Strategies to reduce dynamic hyperinflation in chronic
obstructive pulmonary disease
Sposoby zmniejszania dynamicznego rozdęcia płuc w przewlekłej
obturacyjnej chorobie płuc
Pneumonol. Alergol. Pol. 2009; 77: 192–195
Introduction
The chief complaint of many patients with chro-
nic obstructive pulmonary disease (COPD) is that
they are no longer able to carry out or maintain an
activity of which they were previously capable
[1, 2]. The mechanism of activity limitation is now felt
to be multifactorial, related to muscle dysfunction
as well as to pulmonary factors. A key concept is that
activity limitation (or exercise intolerance) in COPD
is linked to hyperinflation, particularly dynamic
hyperinflation. Discovery of this link between airway
obstruction and activity limitation has led us to seek
physiologic-based strategies to reduce hyperinflation
and, thereby, improve the exercise tolerance of pa-
tients with COPD. Four interventions that reduce hy-
perinflation during exercise have been identified.
These are bronchodilator therapy, inhalation of sup-
plemental oxygen or a helium/oxygen mixture, and
rehabilitative exercise programs.
Pharmacotherapy
At present, bronchodilators are the main phar-
macologic options for improving hyperinflation. The
efficacy of bronchodilators in reducing hyperinfla-
tion during exercise has been shown with various
agents [3–6]. A large, long-term trial with tiotropium
has been selected as a representative study [3]. Tio-
tropium is a once-daily anticholinergic with a pro-
longed bronchodilator effect. In this multicenter stu-
dy, 198 patients with moderate to severe COPD were
randomized to 6 weeks of treatment with either tio-
tropium (18 mg) or placebo, once daily. Exercise to-
lerance was determined by serial constant work-rate
tests at 75% of initial peak work rate obtained du-
ring an incremental exercise test. Hyperinflation
during exercise was measured by serial inspiratory
capacity (IC) maneuvers, which require the patient
to breathe in as deeply as possible every 2 minutes
during exercise. As IC is the total lung capacity (TLC)
minus the end-expiratory lung volume (EELV), and
TLC can be assumed to remain constant during exer-
cise, IC is reduced proportionally as EELV increases
during exercise through dynamic hyperinflation.
Patients taking placebo showed little change
in isotime IC over the 6-week study. In contrast,
patients taking tiotropium had an increase in iso-
time IC as compared with the baseline exercise test
of approximately 200 mL that was maintained over
the 6-week period. Tiotropium-treated patients also
increased minute ventilation by approximately
4 L/min at end of exercise compared with patients
taking placebo, suggesting that treatment amelio-
rates the ventilatory limitation to exercise. This
reduction in hyperinflation yielded an increase in
exercise tolerance. At the end of the 6-week trial,
patients taking tiotropium were able to continue
Richard Casaburi, Strategies to reduce dynamic hyperinflation in chronic obstructive pulmonary disease
193www.pneumonologia.viamedica.pl
tory drive, which decreases respiratory rate. This,
in turn, allows more time to exhale, and hence,
reduces dynamic hyperinflation, which results in
increased exercise endurance.
Inhalation of helium/oxygen mixtures (heliox)
Lung mechanics in ventilatory-limited COPD
patients may also be improved by breathing a low-
-density gas mixture, such as heliox (79% helium
and 21% oxygen). The principle is that breathing
heliox reduces the turbulence caused by flow re-
sistance at high rates of ventilation and, thereby,
improves exercise tolerance by increasing the ma-
ximal minute ventilation possible. This theory has
been substantiated in a study by Palange et al. [12],
the results of which have recently been confirmed
by a study from our group [13]. In the former stu-
dy, 12 patients with moderate to severe COPD
(mean FEV1 = 1.15 L) underwent two constant
work exercise tests at 80% maximum on a cycle
ergometer while breathing either room air or he-
liox in a double-blinded fashion. As before, dyna-
mic hyperinflation was measured by IC maneuvers
during exercise.
Patients breathing heliox more than doubled
their endurance time for a constant work rate cyc-
le ergometer test from a mean of 4.2 minutes with
room air to a mean of 9.0 minutes. At isotime, mi-
nute ventilation when breathing heliox was no
different to when breathing room air, suggesting
both groups had the same degree of ventilatory
drive when doing the same amount of work. Com-
paring responses at end- exercise, however, minu-
te ventilation was significantly increased with he-
liox compared with normal air, supporting the theo-
retical mechanism of action of heliox. The key im-
provement was mean IC, which was significantly
increased at isotime by approximately 200 mL with
heliox compared with room air, and continued to be
significantly increased, even at peak exercise.
Heliox breathing, therefore, functions in a si-
milar way to bronchodilators, in that it decreases
airflow resistance, albeit via a different physical
mechanism. By the same physiologic mechanism,
however, dynamic hyperinflation during exercise
is reduced and exercise tolerance is improved.
Rehabilitative exercise training
Of all the interventions available, a program
of rehabilitative exercise training, when optimal-
ly delivered, generally yields the greatest impro-
vements in exercise tolerance. Rehabilitation pro-
grams used in studies invariably include of lower
exercising for a mean of 21% (1.75 minutes) lon-
ger than patients taking placebo. Bronchodilators,
therefore, improve exercise tolerance by decreasing
the expiratory airflow resistance, which decreases
dynamic hyperinflation during exercise yielding
less dyspnea at a given level of exercise.
Inhaled oxygen
Another approach to improving exercise tole-
rance in COPD is to increase the fraction of oxy-
gen inhaled. Supplemental oxygen is an establi-
shed treatment for hypoxemic patients with COPD,
in whom it improves exercise tolerance and is pro-
ven to prolong life [7]. Evidence also supports be-
nefits of supplemental oxygen in nonhypoxemic
patients — patients for whom supplemental oxy-
gen would not normally be considered [8–11].
In a study performed in our laboratory, pa-
tients performed five constant work-rate exercise
tests on a cycle ergometer at 75% peak work-rate,
each at a different oxygen fraction (performed in
randomized order). Dynamic hyperinflation during
exercise was again assessed by IC maneuver. When
breathing air (21% O2), isotime IRV (the differen-
ce between TLC and end inspiratory lung volume)
is reduced to about 290 mL, compared to healthy
subjects in the same study whose end-exercise
mean IRV when breathing air was 950 mL. When
end-inspiratory volume approaches the TLC so clo-
sely, elastic work of breathing increases substan-
tially because the lungs are on a shallow portion
of their pressure-volume relationship, which re-
sults in greatly, increased dyspnea. Dynamic hy-
perinflation thus forces the patients to stop exer-
cise. When these patients breathed 30% and 50%
oxygen, mean IRV at the same isotime increased
to 480 mL and 540 mL, respectively, suggesting that
hyperinflation was reduced. There were no further
increases in IRV at isotime with 75% and 100%.
Hyperoxia decreased pulmonary ventilation; the
fall in ventilation was wholly due to respiratory
rate decrease. The lower respiratory rate allowed
more time for exhalation, yielding less hyperinfla-
tion. These changes were associated with an im-
pressive increase in exercise endurance time,
which showed a plateau at 50% oxygen and a peak
increase of 160% above that for room air. Breathing
30% oxygen was also quite effective, suggesting
that, at least in these patients, only a modest in-
crease in oxygen fraction is required for an impro-
vement in exercise endurance.
A mechanism supported by these results is
that, in nonhypoxemic patients, supplemental oxy-
gen during high intensity exercise lowers ventila-
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limb exercise training, a clearly beneficial compo-
nent [14]. The mechanisms by which exercise to-
lerance is improved by rehabilitative exercise have
been progressively revealed. The first insight was
that training muscles decreases ventilatory stimu-
lation at a given level of activity due to a reduc-
tion in lactic acid production in the muscles. Ano-
ther cause of exercise cessation is muscle fatigue,
onset of which is slowed by exercise training. It is
now established that dynamic hyperinflation is
also reduced following a rehabilitative exercise-
-training program [15].
In this study, the effects of a training program
on 24 patients with severe COPD (mean age
66 years, mean FEV1 1.02 L) were investigated. The
training program consisted of 45-minute sessions
of high intensity exercise on a cycle ergometer,
3 times a week for 7 weeks. Constant work-rate car-
diopulmonary exercise tests at 75% of peak work
rate in the initial incremental exercise test, featu-
ring serial IC maneuvers, were performed before
and after the training program. Mean difference at
isotime for the group showed that exercise training
lowered minute ventilation by approximately 2 L/min,
lowered the rate of breathing by approximately
3 breaths/minute, and increased IC by approxima-
tely 130 mL. Exercise tolerance was substantially
prolonged.
Endurance exercise training, therefore, simi-
larly to supplemental oxygen, reduces ventilatory
drive and slows breathing frequency during exerci-
se. This allows more time to exhale between bre-
aths, and the resultant reduction in dynamic hyper-
inflation allows activity to be maintained longer.
Improving rehabilitative exercise programs
It is postulated that improving exercise endu-
rance will have a positive effect on the activity of
patients, which itself will further improve exerci-
se endurance. The key initiator of this positive re-
inforcement cycle is to obtain an initial exercise
tolerance improvement that is as large as possible.
To achieve this, patients need to train at higher
exercise intensities to gain a better initial effect.
Mechanistically, this can be achieved by reducing
the degree of hyperinflation through combination
of exercise training with one or more of the other
interventions discussed above, or perhaps other
interventions such as pressure support ventilation
or interval training.
Supporting data from specific studies for the-
se combination approaches currently exists for
bronchodilators and supplemental oxygen [16, 17].
A report studying tiotropium in combination with
an 8-week rehabilitation program in a 25-week,
placebo-controlled trial randomized 108 patients
with severe COPD (mean FEV1 34% of predicted)
to either tiotropium or placebo once daily [16].
Study drug was administered 5 weeks prior to the
rehabilitation program and continued 12 weeks after
completion of the 8 week program. The rehabilita-
tion program was rigorous, with three 45-minute
treadmill exercise sessions carried out at the highest
intensity of exercise the patient could achieve.
The primary outcome was exercise enduran-
ce time on a treadmill set at 80% of the maximum
speed the patient could sustain during an incre-
mental test performed prior to the intervention.
Both groups began the study being able to endure
the exercise test for a mean of approximately
9 minutes. The placebo group showed little impro-
vement above baseline prior to rehabilitation, but
improved to approximately 16 minutes by the end
of rehabilitation, followed by a small decline at
12 weeks after cessation of rehabilitation. In contrast,
all responses were improved with tiotropium. As
expected, tiotropium alone improved exercise en-
durance above placebo (by an average of 16%).
However, this improvement doubled to 32% over
placebo by the end of rehabilitation, and the im-
proved endurance continued after cessation of re-
habilitation, so that the improvement over place-
bo was 42% by the end of the study.
Therefore, improvement in exercise enduran-
ce with the combination of tiotropium and rehabi-
litation was more than additive. This was presu-
mably the result of patients with tiotropium being
effectively bronchodilated, which enabled exerci-
se at a higher intensity during rehabilitation, the-
reby providing a greater benefit from the rehabili-
tation program.
Conclusions
Reducing hyperinflation in patients with
COPD has been shown to be a key mechanism for
improving exercise tolerance. This article has di-
scussed four physiologic-based interventions that
are able to improve exercise tolerance through
a mechanism linked to a reduction in dynamic hy-
perinflation.
Dynamic hyperinflation can be reduced by
either improving airflow during expiration or by
reducing the rate of breathing allowing more time
for expiration. Bronchodilators and heliox decre-
ase airflow resistance, allowing more rapid airflow
during expiration. In contrast, supplemental oxy-
gen and rehabilitative exercise training decrease
ventilatory drive, slow respiration rate, and allow
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the patient more time to exhale. The different me-
chanisms employed in these interventions suggest
that combinations would provide additional bene-
fits. This has already been demonstrated by the
additive benefits shown by combination of tiotro-
pium or supplemental oxygen with rehabilitation.
With such interventions, we have the capacity to
reduce hyperinflation, thereby providing options
for improving the potential for living a fuller life
for patients with COPD.
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